meta_pixel
Tapesearch Logo
Log in
Finding Genius Podcast

The Fourth Era of Cancer Treatment: Where Immunotherapy Meets Precision Medicine

Finding Genius Podcast

Richard Jacobs

Medicine, Health & Fitness

4.41K Ratings

🗓️ 9 July 2021

⏱️ 28 minutes

🧾️ Download transcript

Summary

"All malignant diseases are derived from a normal cell in the body," says Dr. Owen O'Connor, MD, PhD. But how different are the malignant cells from the normal ones, and how hard is it to differentiate one from the other?

This question is at the heart of the 'therapeutic window' problem in cancer treatment. But with new research in full swing, a solution may be within reach.

Press play to learn:

  • The four eras of cancer treatment, and where the future of cancer therapy is headed
  • The problem of the therapeutic window and modern-day chemotherapies, and how a combination of immunotherapy and precision medicine could overcome it
  • The function of B cells in the body; how they behave differently in malignant disease vs. autoimmune disease

Dr. O'Connor is an international authority on lymphoma and drug development with over 25 years of experience in academic medicine. He is also Chief Scientific Officer at TG Therapeutics, a biotechnology company that focuses on targeting diseases related to underlying B cell dysfunction, like non-Hodgkin's lymphoma and some autoimmune diseases.

B cells are a type of white blood cell that produce antibodies designed to rid the body of pathogens. In lymphoma and some autoimmune diseases, however, these normal B cells begin wildly misbehaving or proliferating rapidly. In the case of malignant disease, the goal is to inhibit the proliferation of and kill these B cells; in the case of autoimmune disease, the goal is to suppress their activity and interactions with other cells in the body.

How is this accomplished? And what's wrong with most modern chemotherapies?

Answering these questions leads Dr. O'Connor to discuss the meaning of the therapeutic window and two drugs that have been acquired and studied extensively by the team at TG Therapeutics. One of these drugs is an immunotherapy, and the other is a precision targeted therapy. The idea is that working together, these drugs could provide an effective treatment without the serious downsides of chemotherapies. 

Visit https://www.tgtherapeutics.com/ to learn more. 

Episode also available on Apple Podcasts: apple.co/30PvU9C

Transcript

Click on a timestamp to play from that location

0:00.0

Forget frequently as questions.

0:02.0

Common sense, common knowledge, or Google.

0:05.0

How about advice from a real genius?

0:07.0

95% of people in any profession are good enough to be qualified in license.

0:11.0

5%?

0:12.0

Go above and beyond.

0:13.0

They become very good at what they do.

0:15.0

But only 0.1% are real geniuses.

0:18.0

Richard Jacobs has made his life's mission to find them for you.

0:22.0

He hunts down and interviews geniuses in every field.

0:25.0

Sleep science, cancer, stem cells, ketogenic diets, and more.

0:29.0

Come the geniuses.

0:30.0

This is The Finding Genius Podcast.

0:33.0

The Richard Jacobs.

0:38.0

Before we begin, a note from our sponsor.

0:40.0

I'm Richard Jacobs, executive director of the Nonprofit Finding Genius Foundation, and host

0:45.0

of The Finding Genius Podcast.

0:47.0

In late 2016, I was rear-ended at 65 miles an hour by a truck on the highway, which sent

0:52.6

me off-road into a ditch.

0:54.8

The impact of the collision gave me a concussion and other injuries.

0:58.0

At the hospital, a CT scan showed that I had thyroid nodules, which turned out to be cancer.

1:03.0

It was then when I had a biopsy my neck that I realized, even if I was a million there,

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from Richard Jacobs, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Richard Jacobs and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2026.